In vivo antipyretic, analgesic, and anti-inflammatory activities of the brown alga Ecklonia cava extracts in mice

Fisheries and Aquatic Sciences

Volumn 15, Issue 1, 2012, Pages 73-76

  Kang, Ji Young ^a   Choi, Jae Suk ^b   Park, Nam Gyu ^a   Ahn, Dong Hyun ^a   Hong, Yong Ki ^a  

^a Pukyong National University   (South Korea)

^b Silla University   (South Korea)

Author keywords

Analgesic; Anti inflammation; Antipyretic; Ecklonia cava; In vivo assay; Phaeophyta

Indexed keywords

ECKLONIA CAVA; MUS; PHAEOPHYCEAE;

EID: 84862490715     PISSN: 12269204     EISSN: None     Source Type: Journal    
DOI: 10.5657/FAS.2012.0073     Document Type: Article

References (28)

1. Ahn MJ, Yoon KD, Min SY, Lee JS, Kim JH, Kim TG, Kim SH, Kim NG, Huh H and Kim J. 2004. Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava. Biol Pharm Bull 27, 544-547.
2. Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH and Reading AE. 1985. Pain measurement: an overview. Pain 22, 1-31.
3. Donguibogam Committee. 1999. Translated Donguibogam. Bubinmunwha Press, Seoul, KR.
4. Garrett RH and Grisham CM. 2005. Biochemistry. 3rd ed. Thomson Learning, Inc., Belmont, CA, US.
5. Gray WD, Osterberg AC and Scuto TJ. 1970. Measurement of the analgesic efficacy and potency of pentazocine by the D'Amour and Smith method. J Pharmacol Exp Ther 172, 154-162.
6. Griswold DE, Martin LD, Badger AM, Breton J and Chabot-Fletcher M. 1998. Evaluation of the cutaneous anti-inflammatory activity of azaspiranes. Inflamm Res 47, 56-61.
7. Heo SJ, Ko SC, Cha SH, Kang DH, Park HS, Choi YU, Kim D, Jung WK and Jeon YJ. 2009. Effect of phlorotannins isolated from Ecklonia cava on melanogenesis and their protective effect against photo-oxidative stress induced by UV-B radiation. Toxicol in Vitro 23, 1123-1130.
8. Jin HJ, Kim JH, Sohn CH, DeWreede RE, Choi TJ, Towers GHN, Hudson JB and Hong YK. 1997. Inhibition of Taq DNA polymerase by seaweed extracts from British Columbia, Canada and Korea. J Appl Phycol 9, 383-388.
9. Jung WK, Ahn YW, Lee SH, Choi YH, Kim SK, Yea SS, Choi I, Park SG, Seo SK, Lee SW and Choi IW. 2009. Ecklonia cava ethanolic extracts inhibit lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in BV2 microglia via the MAP kinase and NF-kB pathways. Food Chem Toxicol 47, 410-417.
10. Kang HS, Chung HY, Kim JY, Son BW, Jung HA and Choi JS. 2004. Inhibitory phlorotannins from the edible brown alga Ecklonia stolonifera on total reactive oxygen species (ROS) generation. Arch Pharm Res 27, 194-198.
11. Kang JW. 1968. Illustrated Encyclopedia of Fauna and Flora of Korea. Vol. 8. Marine Algae. Samhwa Press, Seoul, KR.
12. Kang SM, Kim KN, Lee SH, Ahn G, Cha SH, Kim AD, Yang XD, Kang MC and Jeon YJ. 2011. Anti-inflammatory activity of polysaccharide purified from AMG-assistant extract of Ecklonia cava in LPS stimulated RAW 264.7 macrophages. Carbohydr Polym 85, 80-85.
13. Khan MNA, Lee MC, Kang JY, Park NG, Fujita H and Hong YK. 2008. Effects of the brown seaweed Undaria pinnatifida on erythematous inflammation assessed using digital photo analysis. Phytother Res 22, 634-639.
14. Kim MM, Ta QV, Mendis E, Rajapakse N, Jung WK, Byun HG, Jeon YJ and Kim SK. 2006. Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity. Life Sci 79, 1436-1443.
15. Kim SK, Lee DY, Jung WK, Kim JH, Choi I, Park SG, Seo SK, Lee SW, Lee CM, Yea SS, Choi YH and Choi IW. 2008. Effects of Ecklonia cava ethanol extracts on airway hyperresponsiveness and inflammation in a murine asthma model: role of suppressor of cytokine signaling. Biomed Pharmacother 62, 289-296.
16. Koyanagi S, Tanigawa N, Nakagawa H, Soeda S and Shimeno H. 2003. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 65, 173-179.
17. Lee MC, Konishi N and Fujii H. 2003. Blood flow analyses of skin tissue under the sacrum using laser speckle flowgraphy. Opt Rev 10, 562-566.
18. Li Y, Qian ZJ, Ryu B, Lee SH, Kim MM and Kim SK. 2009. Chemical components and its antioxidant properties in vitro: an edible marine brown alga Ecklonia cava. Bioorg Med Chem 17, 1963-1973.
19. Müller-Decker K, Scholz K, Marks E and Fürstenberger G. 1995. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol Carcinog 12, 31-41.
20. Nishizuka Y. 1989. Studies and prospectives of the protein kinase C family for cellular regulation. Cancer 63, 1892-1903.
21. Ragan MA and Glombitza K. 1986. Phlorotannins, brown algal polyphenols. Prog Phycol Res 4, 177-241.
22. Scholz J and Woolf CJ. 2002. Can we conquer pain? Nat Neurosci 5 Suppl, 1062-1067.
23. Shin HC, Hwang HJ, Kang KJ and Lee BH. 2006. An antioxidative and antiinflammatory agent for potential treatment of osteoarthritis from Ecklonia cava. Arch Pharm Res 29, 165-171.
24. Suh KT. 1997. Classification of herbs in decoction part of Donguibogam. Ph.D. Dissertation, Kyungsung University, Busan, KR.
25. Teotino UM, Friz LP, Gandini A and Dellabella D. 1963. Thio derivatives of 2,3-dihydro-4H-1,3-benzoazin-4-one: synthesis and pharmacological properties. J Med Chem 6, 248-250.
26. Tsuchiya M, Sakakibara A and Yamamoto M. 2005. A tachykinin NK1 receptor antagonist attenuates the 4-beta-phorbol-12-myristate-13-acetate-induced nociceptive behaviour in the rat. Eur J Pharmacol 507, 29-34.
27. Wei H and Frenkel K. 1992. Suppression of tumor promoter-induced oxidative events and DNA damage in vivo by sarcophytol A: a possible mechanism of antipromotion. Cancer Res 52, 2298-2303.
28. World Health Organization. 1992. Research Guidelines for Evaluating the Safety and Efficacy of Herbal Medicine. Regional Office for Western Pacific, Manila, PH.